Free tool
FAERS Monitor: Amidate
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018227 or its brand name (Amidate, Etomidate). Reports on generic versions are filed under their own applications.
Reports
2,262
Serious
2,079
92% of reports
Hospitalization
969
Death reported
478
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- renal failure239
- pain205
- injury186
- anxiety181
- drug ineffective175
- unevaluable event168
- hypotension159
- fear154
- cardiac arrest148
- emotional distress144
- renal injury134
- renal impairment127
- death125
- stress116
- anhedonia112
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 60 |
| 2005 | 28 |
| 2006 | 39 |
| 2007 | 32 |
| 2008 | 47 |
| 2009 | 42 |
| 2010 | 72 |
| 2011 | 214 |
| 2012 | 103 |
| 2013 | 60 |
| 2014 | 78 |
| 2015 | 76 |
| 2016 | 96 |
| 2017 | 84 |
| 2018 | 106 |
| 2019 | 87 |
| 2020 | 166 |
| 2021 | 129 |
| 2022 | 123 |
| 2023 | 152 |
| 2024 | 117 |
| 2025 | 195 |
| 2026 | 156 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,897 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| fearSignal | 154 | 53.5 | 45.9 | 7,853 |
| renal injurySignal | 134 | 42.1 | 35.7 | 5,322 |
| anhedoniaSignal | 112 | 39.8 | 33.2 | 4,184 |
| injurySignal | 186 | 24.7 | 21.5 | 4,202 |
| unevaluable eventSignal | 168 | 20.7 | 17.9 | 3,133 |
| renal failureSignal | 239 | 16.8 | 14.9 | 3,543 |
| cardiac arrestSignal | 148 | 16.7 | 14.3 | 2,173 |
| stressSignal | 116 | 15.0 | 12.5 | 1,503 |
| renal impairmentSignal | 127 | 14.1 | 11.9 | 1,534 |
| emotional distressSignal | 144 | 11.1 | 9.5 | 1,315 |
| hypotensionSignal | 159 | 7.4 | 6.3 | 878 |
| anxietySignal | 181 | 5.9 | 5.1 | 744 |
| painSignal | 205 | 3.1 | 2.7 | 299 |
| death | 125 | 1.3 | 1.1 | 11 |
| drug ineffective | 175 | 1.2 | 1.1 | 8 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.